These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 12926656

  • 1. Reduced burden of disease and improved outcome of patients with rheumatoid factor positive rheumatoid arthritis compared with dropouts. A 10 year observational study.
    Darmawan J, Rasker JJ, Nuralim H.
    J Rheumatol Suppl; 2003 Aug; 67():50-3. PubMed ID: 12926656
    [Abstract] [Full Text] [Related]

  • 2. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
    Sokka T, Pincus T.
    J Rheumatol; 2009 Jul; 36(7):1387-90. PubMed ID: 19411389
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F.
    J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
    [Abstract] [Full Text] [Related]

  • 5. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H, Nicola PJ, Crowson CS, O'Fallon WM, Gabriel SE.
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [Abstract] [Full Text] [Related]

  • 6. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis.
    Lopez-Olivo MA, Gonzalez-Lopez L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz EG, Gamez-Nava JI.
    Scand J Rheumatol; 2006 Feb; 35(2):112-6. PubMed ID: 16641044
    [Abstract] [Full Text] [Related]

  • 7. Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins?
    Lacki JK, Samborski W, Mackiewicz S, Mackiewicz U.
    Ups J Med Sci; 1995 Feb; 100(3):233-42. PubMed ID: 8808186
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez P, Nzeusseu Toukap A, Lauwerys BR, Manicourt DH, Verschueren P, Westhovens R, Devogelaer JP, Houssiau FA.
    Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515
    [Abstract] [Full Text] [Related]

  • 10. Ten-year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy.
    Darmawan J, Rasker JJ, Nuralim H.
    J Rheumatol Suppl; 2004 Mar; 69():66-9. PubMed ID: 15053456
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD.
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE, Gülfe A, Saxne T, Geborek P.
    Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
    [Abstract] [Full Text] [Related]

  • 16. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 17. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C, Rekvig OP, Nossent HC.
    Scand J Rheumatol; 2005 Feb; 34(4):269-76. PubMed ID: 16195159
    [Abstract] [Full Text] [Related]

  • 18. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.
    Syngle A, Vohra K, Kaur L, Sharma S.
    Scand J Rheumatol; 2009 Feb; 38(1):15-22. PubMed ID: 18766955
    [Abstract] [Full Text] [Related]

  • 19. [The comparison of clinical features between early rheumatoid arthritis and established rheumatoid arthritis].
    Furuta E, Suenaga Y, Hashimoto M, Shiokawa S, Nonaka S, Wada T, Yasuda M, Shingu M, Nobunaga M.
    Ryumachi; 1994 Jun; 34(3):594-600. PubMed ID: 8052925
    [Abstract] [Full Text] [Related]

  • 20. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z.
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.